isoxazoles has been researched along with Lupus Nephritis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, TM | 1 |
| Bao, H; Chen, YH; Hu, WX; Liu, ZH; Liu, ZZ; Wang, SF; Zhang, HT | 1 |
| Furie, R; Toder, K; Zapantis, E | 1 |
| Cao, H; Chen, Z; Lin, J; Liu, L; Rao, Y; Yang, H; Zhang, X | 1 |
| Jia, Y; Miao, H; Wang, L; Yang, Y; Zhang, XY; Zhou, YS | 1 |
| Cai, GY; Chen, XM; Cui, TG; Hou, FF; Jiang, ZP; Li, YN; Lu, FM; Mei, CL; Ni, ZH; Qian, JQ; Wang, GB; Wang, HY; Wang, YH; Xu, FF; Yu, XQ; Zhang, FS; Zhao, MH; Zhao, XZ; Zhu, TY; Zou, WZ | 1 |
| Jin, XM; Li, YN; Nie, YK; Sun, Y; Yu, HM; Zhang, FS | 1 |
| He, C; Liu, S; Lu, X; Luo, P; Wu, M; Yan, Z; Yu, Y | 1 |
| Bao, CD; Cai, GY; Chen, XM; Cui, TG; Hou, FF; Li, YN; Lu, FM; Mei, CL; Ni, ZH; Qian, JQ; Wang, GB; Wang, HY; Zhang, FS; Zhao, MH; Zhao, XZ; Zhu, TY; Zou, WZ | 1 |
| Lam, CW; Li, EK; Li, WC; Szeto, CC; Tam, LS; Wong, CK | 1 |
3 review(s) available for isoxazoles and Lupus Nephritis
| Article | Year |
|---|---|
Treatment of severe lupus nephritis: the new horizon.
Topics: Antimalarials; Azathioprine; Biological Products; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Nephritis; Mycophenolic Acid; Ribonucleosides; Severity of Illness Index; Sirolimus; Tacrolimus | 2015 |
Lessons Learned From the Clinical Trials of Novel Biologics and Small Molecules in Lupus Nephritis.
Topics: Abatacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Products; Boron Compounds; Bortezomib; Clinical Trials as Topic; Drug Discovery; Glycine; Humans; Immunologic Factors; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Lupus Nephritis; Mycophenolic Acid; Off-Label Use; Oligonucleotides; Quinolones; Recombinant Fusion Proteins; Rituximab; Tacrolimus; Treatment Outcome | 2015 |
The Efficacy and Safety of Leflunomide for the Treatment of Lupus Nephritis in Chinese Patients: Systematic Review and Meta-Analysis.
Topics: Adult; Asian People; Cyclophosphamide; Female; Humans; Isoxazoles; Leflunomide; Lupus Nephritis; Male; Odds Ratio; Remission Induction; Treatment Outcome | 2015 |
3 trial(s) available for isoxazoles and Lupus Nephritis
| Article | Year |
|---|---|
Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone: a prospective multi-centre observational study.
Topics: Adolescent; Adult; Aged; Biopsy; Disease Progression; Female; Humans; Immunosuppressive Agents; Isoxazoles; Kidney; Leflunomide; Lupus Nephritis; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2008 |
[Treatment of proliferative lupus nephritis with leflunomide and steroid: a prospective multi-center controlled clinical trial].
Topics: Adolescent; Adult; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Nephritis; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2005 |
Safety and efficacy of leflunomide in the treatment of lupus nephritis refractory or intolerant to traditional immunosuppressive therapy: an open label trial.
Topics: Adult; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Nephritis; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2006 |
4 other study(ies) available for isoxazoles and Lupus Nephritis
| Article | Year |
|---|---|
Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: a retrospective single-center study.
Topics: Adolescent; Adult; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Isoxazoles; Kidney; Leflunomide; Lupus Nephritis; Male; Mycophenolic Acid; Nephrotic Syndrome; Podocytes; Prednisone; Proteinuria; Remission Induction; Retrospective Studies; Tacrolimus; Treatment Outcome | 2015 |
[Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antinuclear; Arthritis; Cyclophosphamide; Disease Progression; Female; Hematologic Diseases; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Pain; Prognosis; Raynaud Disease; Recurrence; Scleritis; Serositis; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Vision Disorders | 2016 |
The efficacy and safety of leflunomide therapy in lupus nephritis by repeat kidney biopsy.
Topics: Adolescent; Adult; Biopsy; Female; Humans; Immunosuppressive Agents; Isoxazoles; Kidney; Leflunomide; Lupus Nephritis; Male; Middle Aged | 2009 |
Therapeutic effect of leflunomide on the development of experimental lupus nephritis in mice.
Topics: Animals; Antigen-Antibody Complex; Ascites; Cell Proliferation; Disease Models, Animal; Female; Graft vs Host Disease; Immunity, Innate; Immunosuppressive Agents; Isoxazoles; Kidney; Leflunomide; Longevity; Lupus Nephritis; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Signal Transduction; Spleen; Toll-Like Receptor 9 | 2012 |